Company Filing History:
Years Active: 2014
Title: Michal Bereta: Innovator in Bacterial Vaccine Development
Introduction
Michal Bereta is a notable inventor based in Kraków, Poland. He has made significant contributions to the field of biotechnology, particularly in the development of vaccines. His innovative work focuses on utilizing bacterial strains for therapeutic purposes, especially in cancer treatment.
Latest Patents
Michal Bereta holds a patent for a new bacterial strain of enterica serovar VNP20009, which has been deposited in the Polish Collection of Microorganisms under access no. B/00024. This invention relates to its use in the production of a vaccine, particularly an anti-cancer vaccine. The patent also describes a method for obtaining a therapeutic vaccine vector, characterized by the introduction of genetic modifications into the vector strain that are specific to cancer cells. This results in the delayed overexpression of a gene encoding a protein responsible for the invasive ability of this strain.
Career Highlights
Throughout his career, Michal Bereta has worked with prestigious institutions, including Jagiellonian University and Uniwersytet Jagielloński. His research and innovations have contributed to advancements in vaccine technology and cancer treatment.
Collaborations
One of his notable collaborators is Paulina Chorobik, with whom he has worked on various projects related to his inventions.
Conclusion
Michal Bereta's work in the field of bacterial vaccine development showcases his commitment to advancing medical science. His innovative approaches have the potential to significantly impact cancer treatment and vaccine production.